Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel in Children With Refractory Leukemias
NCT00021242Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Aug 2002
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 2, open-label, single-arm trial of docetaxel in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), sponsored by Children's Oncology Group. Primary endpoint: Response to therapy. Started Aug 2002; status: completed.
02
Drugs
docetaxel
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00021242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00021242.